Sol-Gel Technologies Ltd.
SLGL
$79.86
-$4.11-4.90%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
3/13/2026
-
Ticker Report
3/13/2026
-
MarketBeat
3/13/2026
-
Tickeron - Stocks
3/13/2026
-
Tickeron - Stocks
3/12/2026
-
Tickeron - Stocks
3/11/2026
-
Tickeron - Technical Analysis
3/10/2026
-
Tickeron - Stocks
3/10/2026
-
Tickeron - Stocks
3/7/2026
-
Tickeron - Technical Analysis
3/6/2026
-
Tickeron - Stocks
3/6/2026
-
Tickeron - Stocks
3/6/2026
-
Tickeron - Stocks
3/5/2026
-
Tickeron - Stocks
3/5/2026
-
Tickeron - Stocks
3/4/2026
-
Tickeron - Stocks
3/4/2026
-
Tickeron - Stocks
3/4/2026
-
MarketBeat
3/3/2026
-
Tickeron - Technical Analysis
3/3/2026
-
Tickeron - Technical Analysis
3/2/2026
-
MarketBeat
2/28/2026
-
Tickeron - Technical Analysis
2/27/2026
-
Tickeron - Stocks
2/26/2026
-
Tickeron - Stocks
2/24/2026
-
Tickeron - Stocks
2/24/2026
-
Tickeron - Stocks
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Friday, August 15, 2025
Period Date
Monday, June 30, 2025
Next Filing
(est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
972 8 931 3433
Address
7 Golda Meir Street
Ness Ziona, 7403650
Ness Ziona, 7403650
Country
Year Founded
Business Description
Sector
Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland...
more